IndiGo’s Pilot Sprint: Rebuilding a Crew Pipeline Before the Night Sky Closes In
India’s air travel engine doesn’t run on jet fuel alone—it runs on people. And last week,
December 16, 2025
Category: Stocks
WOW Skin Science and the Great Indian Beauty Reset: From Onion-Hair Glory to “WOW 2.0”
In the strangest way, the pandemic gave Indian beauty a cheat code: comfort-first rituals at home,
December 15, 2025
Beyond 2026: Microsoft’s AI Data-Centre Bet Is Reshaping India’s Cloud Future
A quiet race is underway across India—measured not in app downloads or smartphone shipments, but in
December 14, 2025
Mohali’s Fab Gets a Future: How a ₹4,500-Crore Upgrade Could Rewire India’s Industrial Chip Story
The semiconductor conversation in India often feels like a distant skyline—gleaming, ambitious, and always a little
December 13, 2025
From Pin Codes to Predictability: How Meesho’s Valmo Is Rewiring Logistics for India’s Next Billion Shoppers
Six years ago, when Jaya Singh Yadav began selling home décor from her home in Indore,
December 12, 2025
When the Rupee Slips, India’s IT Sector Smiles: Currency Winds Behind a $283B Engine
Wednesday arrived with a headline that usually signals trouble: the Indian rupee sank to a historic
December 11, 2025
Healthify’s American Pivot: When an Indian Wellness App Starts Playing on the World’s Most Expensive Field
Healthify, the Indian digital health and wellness startup that began life as a calorie-tracking app, is
December 10, 2025
When the Code Writers Stop Moving the Index
India’s $283-billion information technology sector used to feel like the metronome of the market—steady, reliable, always
December 9, 2025
The Premium Cement Play: How India’s Mid-Tier Makers Are Chasing Margins Without Raising Prices
The bags may look the same from a distance—grey, heavy, familiar—but India’s cement makers are quietly
December 8, 2025
Dr. Reddy’s and the Semaglutide Breakthrough: A Courtroom Win with a Clear Export-Only Line
Dr. Reddy’s Laboratories has just carved out a meaningful—if carefully fenced—path into the semaglutide opportunity. In
December 7, 2025